Microbix Biosystems Inc. provided earnings guidance for the fiscal year 2022. For the year, the company excepts that fiscal 2022 will realize materially-positive net earnings, as were achieved in fiscal 2021.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.325 CAD | -1.52% | -2.99% | -16.67% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.67% | 32.34M | |
+40.80% | 53.67B | |
+34.44% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- MBX Stock
- News Microbix Biosystems Inc.
- Microbix Biosystems Inc. Provides Earnings Guidance for the Fiscal Year 2022